NASDAQ / LIVE COMPANY INTELLIGENCE

NeOnc Technologies Holdings, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERNTHI
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / NTHI COVERAGE

What’s moving NeOnc Technologies Holdings, Inc. now

Current reporting with the operating signal separated from the noise.

01
marketscreener.com

Neonc Technologies Holdings, Inc. Announces Appointment of Nasim Shomali to Board of Directors, Effective July 1, 2026

The story matters when it changes NeOnc Technologies Holdings, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and ...

New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and ...

The story matters when it changes NeOnc Technologies Holdings, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
NeOnc Technologies Holdings, Inc. Secures Board Approval for Strategic $50 Million Investment with Quazar Investment

NeOnc Technologies Holdings, Inc. Secures Board Approval for Strategic $50 Million Investment with Quazar Investment

The story matters when it changes NeOnc Technologies Holdings, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

The story matters when it changes NeOnc Technologies Holdings, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

The story matters when it changes NeOnc Technologies Holdings, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
NeOnc Technologies Holdings, Inc. Appoints Dr. Steven L. Giannotta to Board of Directors

NeOnc Technologies Holdings, Inc. Appoints Dr. Steven L. Giannotta to Board of Directors

The story matters when it changes NeOnc Technologies Holdings, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
07
NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors

NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors

The story matters when it changes NeOnc Technologies Holdings, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest NTHI filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-05-05 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-15 · Period 2026-07-15SEC ↗8-KMaterial company eventFiled 2026-07-02 · Period 2026-06-27SEC ↗8-KMaterial company eventFiled 2026-06-23 · Period 2026-06-23SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-06-23 · Period 2026-08-14SEC ↗4Official SEC filingFiled 2026-07-13 · Period 2025-07-10SEC ↗
EARNINGS / QUARTERLY TRACKER

NeOnc Technologies Holdings, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.